nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.31	0.538	CbGbCtD
Dicyclomine—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.267	0.462	CbGbCtD
Dicyclomine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000624	0.00148	CcSEcCtD
Dicyclomine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000623	0.00147	CcSEcCtD
Dicyclomine—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000622	0.00147	CcSEcCtD
Dicyclomine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000619	0.00146	CcSEcCtD
Dicyclomine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000619	0.00146	CcSEcCtD
Dicyclomine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000618	0.00146	CcSEcCtD
Dicyclomine—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000616	0.00146	CcSEcCtD
Dicyclomine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000615	0.00146	CcSEcCtD
Dicyclomine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000613	0.00145	CcSEcCtD
Dicyclomine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000611	0.00145	CcSEcCtD
Dicyclomine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000611	0.00144	CcSEcCtD
Dicyclomine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000611	0.00144	CcSEcCtD
Dicyclomine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000608	0.00144	CcSEcCtD
Dicyclomine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000603	0.00143	CcSEcCtD
Dicyclomine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000603	0.00143	CcSEcCtD
Dicyclomine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000601	0.00142	CcSEcCtD
Dicyclomine—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000594	0.00141	CcSEcCtD
Dicyclomine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000592	0.0014	CcSEcCtD
Dicyclomine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000587	0.00139	CcSEcCtD
Dicyclomine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000583	0.00138	CcSEcCtD
Dicyclomine—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000582	0.00138	CcSEcCtD
Dicyclomine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000581	0.00138	CcSEcCtD
Dicyclomine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000581	0.00137	CcSEcCtD
Dicyclomine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00058	0.00137	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000577	0.00136	CcSEcCtD
Dicyclomine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000576	0.00136	CcSEcCtD
Dicyclomine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000575	0.00136	CcSEcCtD
Dicyclomine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000574	0.00136	CcSEcCtD
Dicyclomine—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000573	0.00136	CcSEcCtD
Dicyclomine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000571	0.00135	CcSEcCtD
Dicyclomine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000571	0.00135	CcSEcCtD
Dicyclomine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00057	0.00135	CcSEcCtD
Dicyclomine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000569	0.00134	CcSEcCtD
Dicyclomine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000566	0.00134	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000565	0.00134	CcSEcCtD
Dicyclomine—Malaise—Etoposide—peripheral nervous system neoplasm	0.000564	0.00133	CcSEcCtD
Dicyclomine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000564	0.00133	CcSEcCtD
Dicyclomine—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.000562	0.00133	CcSEcCtD
Dicyclomine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000559	0.00132	CcSEcCtD
Dicyclomine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000559	0.00132	CcSEcCtD
Dicyclomine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000558	0.00132	CcSEcCtD
Dicyclomine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000557	0.00132	CcSEcCtD
Dicyclomine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000557	0.00132	CcSEcCtD
Dicyclomine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000553	0.00131	CcSEcCtD
Dicyclomine—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000552	0.0013	CcSEcCtD
Dicyclomine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00055	0.0013	CcSEcCtD
Dicyclomine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.0013	CcSEcCtD
Dicyclomine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000549	0.0013	CcSEcCtD
Dicyclomine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000549	0.0013	CcSEcCtD
Dicyclomine—Rash—Topotecan—peripheral nervous system neoplasm	0.000549	0.0013	CcSEcCtD
Dicyclomine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000548	0.0013	CcSEcCtD
Dicyclomine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000548	0.0013	CcSEcCtD
Dicyclomine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000546	0.00129	CcSEcCtD
Dicyclomine—Headache—Topotecan—peripheral nervous system neoplasm	0.000545	0.00129	CcSEcCtD
Dicyclomine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000544	0.00129	CcSEcCtD
Dicyclomine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000544	0.00129	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000544	0.00129	CcSEcCtD
Dicyclomine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000544	0.00129	CcSEcCtD
Dicyclomine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000544	0.00129	CcSEcCtD
Dicyclomine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000544	0.00129	CcSEcCtD
Dicyclomine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000543	0.00129	CcSEcCtD
Dicyclomine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000542	0.00128	CcSEcCtD
Dicyclomine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000541	0.00128	CcSEcCtD
Dicyclomine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000541	0.00128	CcSEcCtD
Dicyclomine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00054	0.00128	CcSEcCtD
Dicyclomine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000539	0.00127	CcSEcCtD
Dicyclomine—Pain—Vincristine—peripheral nervous system neoplasm	0.000539	0.00127	CcSEcCtD
Dicyclomine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000539	0.00127	CcSEcCtD
Dicyclomine—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000539	0.00127	CcSEcCtD
Dicyclomine—Rash—Melphalan—peripheral nervous system neoplasm	0.000537	0.00127	CcSEcCtD
Dicyclomine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000537	0.00127	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000535	0.00127	CcSEcCtD
Dicyclomine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000531	0.00126	CcSEcCtD
Dicyclomine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.00053	0.00125	CcSEcCtD
Dicyclomine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000526	0.00124	CcSEcCtD
Dicyclomine—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000526	0.00124	CcSEcCtD
Dicyclomine—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.00123	CcSEcCtD
Dicyclomine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00052	0.00123	CcSEcCtD
Dicyclomine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00052	0.00123	CcSEcCtD
Dicyclomine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000517	0.00122	CcSEcCtD
Dicyclomine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000517	0.00122	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000515	0.00122	CcSEcCtD
Dicyclomine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000515	0.00122	CcSEcCtD
Dicyclomine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000514	0.00121	CcSEcCtD
Dicyclomine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000513	0.00121	CcSEcCtD
Dicyclomine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000513	0.00121	CcSEcCtD
Dicyclomine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000511	0.00121	CcSEcCtD
Dicyclomine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.00051	0.00121	CcSEcCtD
Dicyclomine—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000507	0.0012	CcSEcCtD
Dicyclomine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000506	0.0012	CcSEcCtD
Dicyclomine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000506	0.0012	CcSEcCtD
Dicyclomine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.0005	0.00118	CcSEcCtD
Dicyclomine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000498	0.00118	CcSEcCtD
Dicyclomine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000498	0.00118	CcSEcCtD
Dicyclomine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000497	0.00118	CcSEcCtD
Dicyclomine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000487	0.00115	CcSEcCtD
Dicyclomine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000487	0.00115	CcSEcCtD
Dicyclomine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000484	0.00115	CcSEcCtD
Dicyclomine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000482	0.00114	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000481	0.00114	CcSEcCtD
Dicyclomine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000477	0.00113	CcSEcCtD
Dicyclomine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000475	0.00112	CcSEcCtD
Dicyclomine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000469	0.00111	CcSEcCtD
Dicyclomine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000469	0.00111	CcSEcCtD
Dicyclomine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000464	0.0011	CcSEcCtD
Dicyclomine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000463	0.00109	CcSEcCtD
Dicyclomine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000459	0.00109	CcSEcCtD
Dicyclomine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000458	0.00108	CcSEcCtD
Dicyclomine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000455	0.00108	CcSEcCtD
Dicyclomine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000454	0.00107	CcSEcCtD
Dicyclomine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000452	0.00107	CcSEcCtD
Dicyclomine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000449	0.00106	CcSEcCtD
Dicyclomine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000448	0.00106	CcSEcCtD
Dicyclomine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000445	0.00105	CcSEcCtD
Dicyclomine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000444	0.00105	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000441	0.00104	CcSEcCtD
Dicyclomine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00044	0.00104	CcSEcCtD
Dicyclomine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000437	0.00103	CcSEcCtD
Dicyclomine—Pain—Etoposide—peripheral nervous system neoplasm	0.000437	0.00103	CcSEcCtD
Dicyclomine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000432	0.00102	CcSEcCtD
Dicyclomine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000421	0.000995	CcSEcCtD
Dicyclomine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000419	0.000991	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000417	0.000987	CcSEcCtD
Dicyclomine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000417	0.000986	CcSEcCtD
Dicyclomine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000416	0.000984	CcSEcCtD
Dicyclomine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000982	CcSEcCtD
Dicyclomine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000412	0.000975	CcSEcCtD
Dicyclomine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000412	0.000975	CcSEcCtD
Dicyclomine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000411	0.000971	CcSEcCtD
Dicyclomine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00041	0.000969	CcSEcCtD
Dicyclomine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000406	0.000959	CcSEcCtD
Dicyclomine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000404	0.000955	CcSEcCtD
Dicyclomine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000401	0.000948	CcSEcCtD
Dicyclomine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000401	0.000948	CcSEcCtD
Dicyclomine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.0004	0.000946	CcSEcCtD
Dicyclomine—Rash—Vincristine—peripheral nervous system neoplasm	0.000397	0.00094	CcSEcCtD
Dicyclomine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000397	0.000939	CcSEcCtD
Dicyclomine—Headache—Vincristine—peripheral nervous system neoplasm	0.000395	0.000934	CcSEcCtD
Dicyclomine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000388	0.000919	CcSEcCtD
Dicyclomine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000376	0.00089	CcSEcCtD
Dicyclomine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000376	0.00089	CcSEcCtD
Dicyclomine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000374	0.000885	CcSEcCtD
Dicyclomine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000884	CcSEcCtD
Dicyclomine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000877	CcSEcCtD
Dicyclomine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000366	0.000866	CcSEcCtD
Dicyclomine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000861	CcSEcCtD
Dicyclomine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000859	CcSEcCtD
Dicyclomine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000361	0.000854	CcSEcCtD
Dicyclomine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000354	0.000838	CcSEcCtD
Dicyclomine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000835	CcSEcCtD
Dicyclomine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000351	0.000831	CcSEcCtD
Dicyclomine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000351	0.00083	CcSEcCtD
Dicyclomine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000829	CcSEcCtD
Dicyclomine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000824	CcSEcCtD
Dicyclomine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000818	CcSEcCtD
Dicyclomine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000814	CcSEcCtD
Dicyclomine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000806	CcSEcCtD
Dicyclomine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000338	0.000799	CcSEcCtD
Dicyclomine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000796	CcSEcCtD
Dicyclomine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000795	CcSEcCtD
Dicyclomine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000331	0.000783	CcSEcCtD
Dicyclomine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000782	CcSEcCtD
Dicyclomine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.000772	CcSEcCtD
Dicyclomine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000325	0.00077	CcSEcCtD
Dicyclomine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000325	0.000768	CcSEcCtD
Dicyclomine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000767	CcSEcCtD
Dicyclomine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000762	CcSEcCtD
Dicyclomine—Rash—Etoposide—peripheral nervous system neoplasm	0.000322	0.000761	CcSEcCtD
Dicyclomine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000322	0.000761	CcSEcCtD
Dicyclomine—Headache—Etoposide—peripheral nervous system neoplasm	0.00032	0.000757	CcSEcCtD
Dicyclomine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000753	CcSEcCtD
Dicyclomine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000748	CcSEcCtD
Dicyclomine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000745	CcSEcCtD
Dicyclomine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000744	CcSEcCtD
Dicyclomine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000733	CcSEcCtD
Dicyclomine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000729	CcSEcCtD
Dicyclomine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000723	CcSEcCtD
Dicyclomine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000303	0.000717	CcSEcCtD
Dicyclomine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000716	CcSEcCtD
Dicyclomine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000712	CcSEcCtD
Dicyclomine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000705	CcSEcCtD
Dicyclomine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000698	CcSEcCtD
Dicyclomine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000692	CcSEcCtD
Dicyclomine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000691	CcSEcCtD
Dicyclomine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000688	CcSEcCtD
Dicyclomine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000683	CcSEcCtD
Dicyclomine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000678	CcSEcCtD
Dicyclomine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000677	CcSEcCtD
Dicyclomine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000677	CcSEcCtD
Dicyclomine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000675	CcSEcCtD
Dicyclomine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000666	CcSEcCtD
Dicyclomine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000664	CcSEcCtD
Dicyclomine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000663	CcSEcCtD
Dicyclomine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000279	0.000661	CcSEcCtD
Dicyclomine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000646	CcSEcCtD
Dicyclomine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000645	CcSEcCtD
Dicyclomine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000639	CcSEcCtD
Dicyclomine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000632	CcSEcCtD
Dicyclomine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000626	CcSEcCtD
Dicyclomine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000626	CcSEcCtD
Dicyclomine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000616	CcSEcCtD
Dicyclomine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000614	CcSEcCtD
Dicyclomine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000612	CcSEcCtD
Dicyclomine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000611	CcSEcCtD
Dicyclomine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000608	CcSEcCtD
Dicyclomine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000604	CcSEcCtD
Dicyclomine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000602	CcSEcCtD
Dicyclomine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000597	CcSEcCtD
Dicyclomine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000596	CcSEcCtD
Dicyclomine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000588	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000584	CcSEcCtD
Dicyclomine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000584	CcSEcCtD
Dicyclomine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000579	CcSEcCtD
Dicyclomine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000579	CcSEcCtD
Dicyclomine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000566	CcSEcCtD
Dicyclomine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000562	CcSEcCtD
Dicyclomine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000558	CcSEcCtD
Dicyclomine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000558	CcSEcCtD
Dicyclomine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000557	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000554	CcSEcCtD
Dicyclomine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000551	CcSEcCtD
Dicyclomine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000544	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000541	CcSEcCtD
Dicyclomine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.00054	CcSEcCtD
Dicyclomine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000538	CcSEcCtD
Dicyclomine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000536	CcSEcCtD
Dicyclomine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000536	CcSEcCtD
Dicyclomine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000535	CcSEcCtD
Dicyclomine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000516	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000512	CcSEcCtD
Dicyclomine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000499	CcSEcCtD
Dicyclomine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000498	CcSEcCtD
Dicyclomine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000495	CcSEcCtD
Dicyclomine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000486	CcSEcCtD
Dicyclomine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000479	CcSEcCtD
Dicyclomine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000461	CcSEcCtD
Dicyclomine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000449	CcSEcCtD
Dicyclomine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000448	CcSEcCtD
Dicyclomine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000443	CcSEcCtD
Dicyclomine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000182	0.00043	CcSEcCtD
Dicyclomine—Rash—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000427	CcSEcCtD
Dicyclomine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000426	CcSEcCtD
Dicyclomine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000424	CcSEcCtD
Dicyclomine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000414	CcSEcCtD
Dicyclomine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000402	CcSEcCtD
Dicyclomine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000398	CcSEcCtD
Dicyclomine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000395	CcSEcCtD
Dicyclomine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000395	CcSEcCtD
Dicyclomine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000392	CcSEcCtD
Dicyclomine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000372	CcSEcCtD
